Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Evaluation of a Transrectal Scintigraphic Detector (Proxiscan) for Detection of Primary Prostate Cancer Utilizing a Radiotracer Targeting Prostate Specific Membrane Antigen (PMSA)

NCT01394042 is registered in ClinicalTrials.gov with Radiological Associates of Sacramento Medical Group Inc. as lead sponsor.

NCT NCT01394042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01394042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Evaluation of a Transrectal Scintigraphic Detector (Proxiscan) for Detection of Primary Prostate Cancer Utilizing a Radiotracer Targeting Prostate Specific Membrane Antigen (PMSA)
Lead sponsor
Radiological Associates of Sacramento Medical Group Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2011
Completion date
March 31, 2012
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer